Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients
1 other identifier
interventional
69
1 country
5
Brief Summary
A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery. Symptoms include cough, fatigue, dyspnea, pain, and brain fog (cognitive impairment, including confusion and memory loss), which have a negative impact on daily activities. Homoeopathic practitioners from around the world have documented a number of successful cases of Post COVID treatment. Even though evidence from practice-based research is limited, the purpose of the current study was to evaluate the effect of individualized homoeopathy treatment on post-COVID syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2023
CompletedFirst Submitted
Initial submission to the registry
February 6, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedFebruary 8, 2023
February 1, 2023
4 months
February 6, 2023
February 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cough severity
Severity from 0-10 visual analog scale, where 0 is none to 10 is most severe.
8 weeks
Secondary Outcomes (3)
Change in dyspnea
8 weeks
Change in Fatigue
8 weeks
change in Quality of Life
8 weeks
Study Arms (2)
Homeopathy Group
EXPERIMENTALIndividualized Homeopathy Treatment provided by homeopathic physicians
Standard Group
NO INTERVENTIONUsual care provided by primary care physicians were followed by patients in the standard group
Interventions
Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
Eligibility Criteria
You may qualify if:
- Confirmed COVID-19 history
- Persistent respiratory symptoms for more than three months after COVID-19
- Able to provide informed consent
You may not qualify if:
- Presence of respiratory issues without COVID-19 diagnosis
- On complementary and Alternative Treatment
- Symptoms of infection
- Pregnancy or Breastfeeding
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Innowage Limitedlead
- Gyansanjeevani Indiacollaborator
- Collaborative Homeopathy Research Networkcollaborator
Study Sites (5)
Gyansanjeevani India
Dausa, Rajasthan, India
Gyansanjeevani India
Jaipur, Rajasthan, India
Gyansanjeevani India
Mandāwa, Rajasthan, India
Gyansanjeevani India
Sawai Madhopur, Rajasthan, India
Gyansanjeevani India
Sīkar, Rajasthan, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sadhana Sharma
Gyansanjeevani India
- STUDY DIRECTOR
Vesna Marinković
Collaborative Homeopathy Research Network
- STUDY CHAIR
Neha Sharma
Innowage Limited
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2023
First Posted
February 8, 2023
Study Start
August 6, 2022
Primary Completion
December 18, 2022
Study Completion
January 12, 2023
Last Updated
February 8, 2023
Record last verified: 2023-02